Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 209

1.

Selection of HBV preS1-binding penta-peptides by phage display.

He Y, Ye X, Tiollais P, Zhang J, Zhang J, Liu J, Xie Y.

Acta Biochim Biophys Sin (Shanghai). 2014 Aug;46(8):691-8. doi: 10.1093/abbs/gmu049.

PMID:
24966187
2.

Novel recombinant hepatitis B virus vectors efficiently deliver protein and RNA encoding genes into primary hepatocytes.

Hong R, Bai W, Zhai J, Liu W, Li X, Zhang J, Cui X, Zhao X, Ye X, Deng Q, Tiollais P, Wen Y, Liu J, Xie Y.

J Virol. 2013 Jun;87(12):6615-24. doi: 10.1128/JVI.03328-12. Epub 2013 Apr 3.

3.

Human tetraspanin transmembrane 4 superfamily member 4 or intestinal and liver tetraspan membrane protein is overexpressed in hepatocellular carcinoma and accelerates tumor cell growth.

Li Y, Wang L, Qiu J, Da L, Tiollais P, Li Z, Zhao M.

Acta Biochim Biophys Sin (Shanghai). 2012 Mar;44(3):224-32. doi: 10.1093/abbs/gmr124. Epub 2012 Jan 10.

PMID:
22236579
4.

Hepatitis B virus X protein reduces starvation-induced cell death through activation of autophagy and inhibition of mitochondrial apoptotic pathway.

Mao Y, Da L, Tang H, Yang J, Lei Y, Tiollais P, Li T, Zhao M.

Biochem Biophys Res Commun. 2011 Nov 11;415(1):68-74. doi: 10.1016/j.bbrc.2011.10.013. Epub 2011 Oct 12.

PMID:
22020078
5.

The human LIS1 is downregulated in hepatocellular carcinoma and plays a tumor suppressor function.

Xing Z, Tang X, Gao Y, Da L, Song H, Wang S, Tiollais P, Li T, Zhao M.

Biochem Biophys Res Commun. 2011 Jun 3;409(2):193-9. doi: 10.1016/j.bbrc.2011.04.117. Epub 2011 May 1.

PMID:
21569763
6.

HIV-Tat-mediated delivery of an LPTS functional fragment inhibits telomerase activity and tumorigenicity of hepatoma cells.

Chen G, Da L, Wang H, Xu Y, Chen G, Sun C, Wang L, Zhao J, Zhang F, Feng J, Wang Y, Tiollais P, Li T, Zhao M.

Gastroenterology. 2011 Jan;140(1):332-43. doi: 10.1053/j.gastro.2010.08.046. Epub 2010 Nov 20.

PMID:
20816839
7.

Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC): molecular mechanisms and novel paradigms.

Brechot C, Kremsdorf D, Soussan P, Pineau P, Dejean A, Paterlini-Brechot P, Tiollais P.

Pathol Biol (Paris). 2010 Aug;58(4):278-87. doi: 10.1016/j.patbio.2010.05.001. Epub 2010 Jul 27. Review.

PMID:
20667665
8.

The hepatitis B.

Tiollais P, Chen Z.

Pathol Biol (Paris). 2010 Aug;58(4):243-4. doi: 10.1016/j.patbio.2010.04.002. Epub 2010 Jul 17. No abstract available.

PMID:
20638800
9.

Entry of hepatitis B virus: mechanism and new therapeutic target.

Xie Y, Zhai J, Deng Q, Tiollais P, Wang Y, Zhao M.

Pathol Biol (Paris). 2010 Aug;58(4):301-7. doi: 10.1016/j.patbio.2010.04.001. Epub 2010 May 31. Review.

PMID:
20570056
10.

Molecular biology of the hepatitis B virus and role of the X gene.

Wei Y, Neuveut C, Tiollais P, Buendia MA.

Pathol Biol (Paris). 2010 Aug;58(4):267-72. doi: 10.1016/j.patbio.2010.03.005. Epub 2010 May 18. Review.

PMID:
20483545
11.

Hepatitis B vaccines: protective efficacy and therapeutic potential.

Michel ML, Tiollais P.

Pathol Biol (Paris). 2010 Aug;58(4):288-95. doi: 10.1016/j.patbio.2010.01.006. Epub 2010 Apr 10. Review.

PMID:
20382485
12.

[Hepatitis B vaccination: a major player in the control of primary liver cancer].

Pineau P, Tiollais P.

Pathol Biol (Paris). 2010 Dec;58(6):444-53. doi: 10.1016/j.patbio.2009.03.004. Epub 2009 Nov 5. Review. French.

PMID:
19896296
13.

Hepatitis B virus X protein sensitizes cells to starvation-induced autophagy via up-regulation of beclin 1 expression.

Tang H, Da L, Mao Y, Li Y, Li D, Xu Z, Li F, Wang Y, Tiollais P, Li T, Zhao M.

Hepatology. 2009 Jan;49(1):60-71. doi: 10.1002/hep.22581. Erratum in: Hepatology. 2010 Sep;52(3):1176.

PMID:
19065679
14.

Identification and characterization of peptides that interact with hepatitis B virus via the putative receptor binding site.

Deng Q, Zhai JW, Michel ML, Zhang J, Qin J, Kong YY, Zhang XX, Budkowska A, Tiollais P, Wang Y, Xie YH.

J Virol. 2007 Apr;81(8):4244-54. Epub 2006 Dec 27.

15.

Homozygous deletions scanning in tumor cell lines detects previously unsuspected loci.

Pineau P, Marchio A, Cordina E, Tiollais P, Dejean A.

Int J Cancer. 2003 Aug 20;106(2):216-23.

16.

Homozygous deletion scanning in hepatobiliary tumor cell lines reveals alternative pathways for liver carcinogenesis.

Pineau P, Marchio A, Nagamori S, Seki S, Tiollais P, Dejean A.

Hepatology. 2003 Apr;37(4):852-61.

PMID:
12668978
17.

Mutation analysis of novel human liver-related putative tumor suppressor gene in hepatocellular carcinoma.

Liao C, Zhao MJ, Zhao J, Song H, Pineau P, Marchio A, Dejean A, Tiollais P, Wang HY, Li TP.

World J Gastroenterol. 2003 Jan;9(1):89-93.

18.

Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features.

Wei Y, Van Nhieu JT, Prigent S, Srivatanakul P, Tiollais P, Buendia MA.

Hepatology. 2002 Sep;36(3):692-701.

PMID:
12198663
19.

Recurrent allelic deletions at mouse chromosomes 4 and 14 in Myc-induced liver tumors.

Wu Y, Renard CA, Apiou F, Huerre M, Tiollais P, Dutrillaux B, Buendia MA.

Oncogene. 2002 Feb 28;21(10):1518-26.

20.

[The hepatitis B virus. An example of a medical application of genetic genius].

Tiollais P.

Ann Biol Clin (Paris). 2001 Nov-Dec;59(6):673-5. French. No abstract available.

21.

Chromosomal abnormalities in liver cell dysplasia detected by comparative genomic hybridisation.

Marchio A, Terris B, Meddeb M, Pineau P, Duverger A, Tiollais P, Bernheim A, Dejean A.

Mol Pathol. 2001 Aug;54(4):270-4.

22.

Efficacy and limitations of a specific immunotherapy in chronic hepatitis B.

Pol S, Nalpas B, Driss F, Michel ML, Tiollais P, Denis J, Brécho C; Multicenter study group.

J Hepatol. 2001 Jun;34(6):917-21.

PMID:
11451177
23.

CpG oligodeoxynucleotides with hepatitis B surface antigen (HBsAg) for vaccination in HBsAg-transgenic mice.

Malanchère-Brès E, Payette PJ, Mancini M, Tiollais P, Davis HL, Michel ML.

J Virol. 2001 Jul;75(14):6482-91.

24.

Immunotherapy of chronic hepatitis B by anti HBV vaccine: from present to future.

Michel ML, Pol S, Brechot C, Tiollais P.

Vaccine. 2001 Mar 21;19(17-19):2395-9. Review.

PMID:
11257367
25.

Correct binding of viral X protein to UVDDB-p127 cellular protein is critical for efficient infection by hepatitis B viruses.

Sitterlin D, Bergametti F, Tiollais P, Tennant BC, Transy C.

Oncogene. 2000 Sep 7;19(38):4427-31.

26.

Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patients.

Marchio A, Pineau P, Meddeb M, Terris B, Tiollais P, Bernheim A, Dejean A.

Oncogene. 2000 Aug 3;19(33):3733-8.

27.

Hepatocellular carcinoma in WHV/N-myc2 transgenic mice: oncogenic mutations of beta-catenin and synergistic effect of p53 null alleles.

Renard CA, Fourel G, Bralet MP, Degott C, De La Coste A, Perret C, Tiollais P, Buendia MA.

Oncogene. 2000 May 18;19(22):2678-86.

28.

A genomic approach of the hepatitis C virus generates a protein interaction map.

Flajolet M, Rotondo G, Daviet L, Bergametti F, Inchauspé G, Tiollais P, Transy C, Legrain P.

Gene. 2000 Jan 25;242(1-2):369-79.

PMID:
10721731
29.

Effect of TT virus infection on hepatocellular carcinoma development: results of a Euro-Asian survey.

Pineau P, Meddeb M, Raselli R, Qin LX, Terris B, Tang ZY, Tiollais P, Mazzaferro V, Dejean A.

J Infect Dis. 2000 Mar;181(3):1138-42.

PMID:
10720542
30.

[Genetic vaccination. Perspectives for the prevention and treatment of hepatitis B].

Tiollais P, Michel ML.

C R Acad Sci III. 1999 Nov;322(11):979-81. Review. French.

PMID:
10646093
31.

Close correlation between beta-catenin gene alterations and nuclear accumulation of the protein in human hepatocellular carcinomas.

Terris B, Pineau P, Bregeaud L, Valla D, Belghiti J, Tiollais P, Degott C, Dejean A.

Oncogene. 1999 Nov 11;18(47):6583-8.

32.

Muscle-specific expression of hepatitis B surface antigen: no effect on DNA-raised immune responses.

Loirat D, Li Z, Mancini M, Tiollais P, Paulin D, Michel ML.

Virology. 1999 Jul 20;260(1):74-83.

33.

The proapoptotic effect of hepatitis B virus HBx protein correlates with its transactivation activity in stably transfected cell lines.

Bergametti F, Prigent S, Luber B, Benoit A, Tiollais P, Sarasin A, Transy C.

Oncogene. 1999 May 6;18(18):2860-71.

34.

Specific vaccine therapy in chronic hepatitis B: induction of T cell proliferative responses specific for envelope antigens.

Couillin I, Pol S, Mancini M, Driss F, Bréchot C, Tiollais P, Michel ML.

J Infect Dis. 1999 Jul;180(1):15-26. Erratum in: J Infect Dis 1999 Nov;180(5):1756.

PMID:
10353856
35.

Identification of three distinct regions of allelic deletions on the short arm of chromosome 8 in hepatocellular carcinoma.

Pineau P, Nagai H, Prigent S, Wei Y, Gyapay G, Weissenbach J, Tiollais P, Buendia MA, Dejean A.

Oncogene. 1999 May 20;18(20):3127-34.

36.

Immunization with a plasmid encoding a modified hepatitis B surface antigen carrying the receptor binding site for hepatocytes.

Hui J, Mancini M, Li G, Wang Y, Tiollais P, Michel ML.

Vaccine. 1999 Mar 26;17(13-14):1711-8.

PMID:
10194827
38.

p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro.

Terradillos O, Pollicino T, Lecoeur H, Tripodi M, Gougeon ML, Tiollais P, Buendia MA.

Oncogene. 1998 Oct 22;17(16):2115-23.

39.
40.
41.

[Hepatitis B virus and hepatocellular carcinoma].

Tiollais P, Pineau P, Wei Y, Dejean A, Buendia MA.

Bull Acad Natl Med. 1998;182(1):73-7; discussion 77-8. French.

PMID:
9622933
42.

Extensive analysis of duplicated-inverted hepatitis B virus integrations in human hepatocellular carcinoma.

Pineau P, Marchio A, Mattei MG, Kim WH, Youn JK, Tiollais P, Dejean A.

J Gen Virol. 1998 Mar;79 ( Pt 3):591-600.

PMID:
9519839
43.

In vivo induction of specific cytotoxic T lymphocytes in mice and rhesus macaques immunized with DNA vector encoding an HIV epitope fused with hepatitis B surface antigen.

Le Borgne S, Mancini M, Le Grand R, Schleef M, Dormont D, Tiollais P, Rivière Y, Michel ML.

Virology. 1998 Jan 20;240(2):304-15.

44.

Functional analysis of ground squirrel hepatitis virus enhancer II.

Fourel G, Ringeisen F, Flajolet M, Tiollais P, Buendia MA.

J Virol. 1998 Feb;72(2):1616-22.

45.

Cellular and viral trans-acting factors modulate N-myc2 promoter activity in woodchuck liver tumors.

Flajolet M, Gegonne A, Ghysdael J, Tiollais P, Buendia MA, Fourel G.

Oncogene. 1997 Aug 28;15(9):1103-10.

47.

Comprehensive allelotyping of human hepatocellular carcinoma.

Nagai H, Pineau P, Tiollais P, Buendia MA, Dejean A.

Oncogene. 1997 Jun 19;14(24):2927-33.

48.

DNA-based immunization against hepatitis B surface antigen (HBsAg) in normal and HBsAg-transgenic mice.

Davis HL, Brazolot Millan CL, Mancini M, McCluskie MJ, Hadchouel M, Comanita L, Tiollais P, Whalen RG, Michel ML.

Vaccine. 1997 Jun;15(8):849-52.

PMID:
9234531
49.
50.

Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization.

Marchio A, Meddeb M, Pineau P, Danglot G, Tiollais P, Bernheim A, Dejean A.

Genes Chromosomes Cancer. 1997 Jan;18(1):59-65.

PMID:
8993981

Supplemental Content

Loading ...
Support Center